Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Deadline to join drug distributors' $21 billion U.S. opioid settlement extended

Published 12/22/2021, 06:44 PM
Updated 12/22/2021, 07:05 PM
© Reuters. FILE PHOTO: Tablets of the opioid-based Hydrocodone at a pharmacy in Portsmouth, Ohio, June 21, 2017.  REUTERS/Bryan Woolston

By Nate Raymond

(Reuters) - The three largest U.S. drug distributors announced on Wednesday an extension to a key Jan. 2 deadline for cities and counties to join a proposed $21 billion settlement resolving claims that the companies fueled the nation's opioid epidemic.

Plaintiffs' lawyers who negotiated the deal with McKesson Corp (NYSE:MCK), AmerisourceBergen (NYSE:ABC) Corp and Cardinal Health Inc (NYSE:CAH) called the three-week extension a positive development that would allow some holdout states and their local governments to sign on. The new deadline is Jan. 26.

More than 3,300 lawsuits largely by state and local governments have been filed seeking to hold those and other companies responsible for an opioid abuse crisis that led to hundreds of thousands of overdose deaths over two decades. The companies deny wrongdoing.

The distributors said in September that 42 states, five territories and Washington, D.C., had agreed to participate in the global settlement. A similar number backed a related $5 billion deal with Johnson & Johnson (NYSE:JNJ).

About $10.7 billion of the overall $26 billion is tied to the extent that cities, town and counties participate, and local government councils have been voting in recent weeks to join and resolve their claims.

Peter Mougey, a plaintiffs' lawyer involved in the settlement, said there had been a "huge groundswell of support" and that he expected nearly 80% of local governments that sued to be on board.

But Mougey, a partner at Levin Papantonio, and Paul Geller, a lead negotiator at plaintiffs' law firm Robbins Geller Rudman & Dowd, said more time was needed to allow more states to join. New Mexico on Dec. 7 signed on, and Mougey said more are close.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"A combination of additional states signing on along with the natural impact of the holidays - which are both positives - led the parties to recognize a short extension made sense," Geller said in a statement.

Geller said he expected a similar deadline extension for J&J, which had no comment.

AmerisourceBergen said it "remains optimistic that additional states and municipalities will sign on during the extension beyond the original deadline."

(This story adds missing quote mark in eighth paragraph)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.